FORCE

The primary goal of FORCE is to improve treatment outcomes for rare cancers by developing a data warehouse containing clinicopathological data, imaging data, and a large-scale biobank of samples from donors with rare cancers. This comprehensive repository enables high-quality research on rare cancers.

The FORCE cohorts will support research primarily focused on assessing the value and efficacy of USccfDNA assays in early detection, personalized treatment, and follow-up of rare cancers.

Secondary goals:

• Identifying and validating novel markers for diagnosis, prognosis, follow-up, therapy stratification, and treatment evaluation.
• Gaining a comprehensive understanding of the long-term biology of rare cancers.
• Enhancing clinical decision-making.
• Improving treatment outcomes.
• Facilitating early detection of rare cancers.